obesity drug news today glp-1 today Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine New Guidelines on GLP-1 Drugs
Description
The injection is given subcutaneously once a week
Professor Hanever was the one who discovered the existence of GLP-1
Efpeglenatide, formulated using advanced Fc-PEG conjugation technology, exhibited dose-dependent gastrointestinal adverse events consistent with the GLP-1 class profile
TheofilisPSagrisMOikonomouEAntonopoulosASSiasosGTsioufisCet alInflammatory mechanisms contributing to endothelial dysfunction
